The most common adverse drug reactions of entecavir have been headache, fatigue, dizziness, and nausea. Lactic acidosis, usually associated with severe hepatomegaly and steatosis, has been associated with treatment with nucleoside reverse transcriptase inhibitors. Entecavir is carcinogenic in rodents, but a relationship with human cancer has not been established.